<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04352036</url>
  </required_header>
  <id_info>
    <org_study_id>RC19_0418</org_study_id>
    <nct_id>NCT04352036</nct_id>
  </id_info>
  <brief_title>Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)</brief_title>
  <acronym>COVER</acronym>
  <official_title>Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our primary objective with this cohort will be to define the different phenotypes of acute
      hidrosadenitis, the characterization of which is essential to define suitable therapeutic
      approaches. Indeed, our recent data allow us to note that there would be different phenotypes
      of acute hidrosadenitis and therefore different pathologies inducing different follow-ups and
      care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 20, 2020</start_date>
  <completion_date type="Anticipated">February 20, 2030</completion_date>
  <primary_completion_date type="Anticipated">February 20, 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of the natural history and identification of the different clinical forms of acute hidrosadenitis</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>history of the disease, classification of Hurley, Canoui-Poitrine and van der Zee and Jemec</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of severe forms (grade II, III)</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>Number of patients with severe disease (grades II and III)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Definition of different phenotypes of acute hidrosadenitis</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>patient history, Canoui-Poitrine and van der Zee and Jemec classification, blood and urine tests, imaging</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify the environmental factors associated with the chronicity of the disease</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>socio-demographic data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify the environmental factors associated with the chronicity of the disease</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>questionnaire for collecting dietary habits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify the environmental factors associated with the chronicity of the disease</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>biological nutritional assessment research for a dysmetabolic syndrome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify the environmental factors associated with the chronicity of the disease</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>research for a dysmetabolic syndrome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Identify the environmental factors associated with the chronicity of the disease</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>lifestyle questionnaire assessing the impact on quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Involvement of innate immunity in the development of this chronic inflammation with skin biopsies for bacteriological samples</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>skin biopsies of a closed nodule and axillary and inguinal bacteriological samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine the impact of vitamin D deficiency on inflammatory bowel disease</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>skin biopsies of a closed nodule and axillary and inguinal bacteriological samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine the impact of IGF1 deficiency on inflammatory bowel disease</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
    <description>skin biopsies of a closed nodule and axillary and inguinal bacteriological samples</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">465</enrollment>
  <condition>Acute Hidrosadenitis</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no interventional study</intervention_name>
    <description>no interventional study</description>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      skin biopsies and bacteriological samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The population studied will relate to patients consulting or being hospitalized for Acute
        Hidrosadenitis, whatever its severity.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient diagnosed with acute hidrosadenitis by a dermatologist

          -  Patient agreeing to be part of the study

        Exclusion Criteria:

          -  No affiliation to a social security scheme

          -  Major under guardianship

          -  Protected persons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Brigitte Dreno, PU-PH</last_name>
    <phone>0240083118</phone>
    <email>brigitte.dreno@wanadoo.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliette Delaunay, PH</last_name>
      <email>judelaunay@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chru Brest</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Laurent MISERY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHD Vendée</name>
      <address>
        <city>La Roche Sur Yon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole POIRAUD</last_name>
      <email>carole.poiraud@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Carole POIRAUD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH La Rochelle</name>
      <address>
        <city>La Rochelle</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Celerier, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Hervé MAILLARD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH bretagne sud</name>
      <address>
        <city>Lorient</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>caroline JACOBZONE-LEVEQUE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes - Dermatologie</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte Dreno, PU PH</last_name>
    </contact>
    <investigator>
      <last_name>Brigitte Dreno, PU PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chr D'Orléans</name>
      <address>
        <city>Orléans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>eric esteve</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Milétrie</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ewa WIERZBICKA-HAINAUT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch de Cornouaille</name>
      <address>
        <city>Quimper</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>patrice plantin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alain DUPUY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ch Saint-Brieuc</name>
      <address>
        <city>Saint-Brieuc</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>gilles safa</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annabel Maruani, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 10, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2020</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hidradenitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

